The Health Insurance Review and Assessment Service's Pharmaceutical Management Department was selected as 'best project' among 'self-promoted projects to improve integrity’ for its efforts in improving standard forms and expanding information disclosure systems.

The department worked to improve integrity by clarifying and making transparent the application process for the decision-making of pharmaceutical benefits.

Specifically, the department expanded the scope of information disclosed from the Pharmaceutical Benefit Appraisal Committee (PBAC) meeting to the cost-effectiveness data. In the past, the data shared after the meeting was focused around clinical efficacy data.